Handelsbanken Fonder AB Buys 4,394 Shares of HCA Healthcare, Inc. $HCA

Handelsbanken Fonder AB lifted its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 2.3% during the 2nd quarter, HoldingsChannel reports. The fund owned 198,212 shares of the company’s stock after purchasing an additional 4,394 shares during the period. Handelsbanken Fonder AB’s holdings in HCA Healthcare were worth $75,935,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. Chung Wu Investment Group LLC bought a new position in HCA Healthcare in the 2nd quarter valued at approximately $27,000. Clearstead Trust LLC lifted its holdings in shares of HCA Healthcare by 311.8% during the second quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock worth $27,000 after purchasing an additional 53 shares during the period. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the second quarter valued at $27,000. Cheviot Value Management LLC acquired a new position in HCA Healthcare during the 1st quarter worth about $26,000. Finally, Saudi Central Bank acquired a new stake in shares of HCA Healthcare in the first quarter valued at about $26,000. 62.73% of the stock is owned by institutional investors and hedge funds.

HCA Healthcare Price Performance

Shares of HCA Healthcare stock opened at $476.55 on Friday. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $485.74. The business has a 50-day simple moving average of $439.27 and a 200 day simple moving average of $399.79. The firm has a market capitalization of $108.74 billion, a price-to-earnings ratio of 18.42, a PEG ratio of 1.38 and a beta of 1.41.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a negative return on equity of 792.25% and a net margin of 8.53%.The firm had revenue of $19.16 billion during the quarter, compared to the consensus estimate of $18.55 billion. During the same quarter in the previous year, the company posted $4.90 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Shareholders of record on Monday, December 15th will be given a $0.72 dividend. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 annualized dividend and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Wall Street Analyst Weigh In

HCA has been the topic of several analyst reports. Weiss Ratings reiterated a “buy (b)” rating on shares of HCA Healthcare in a report on Monday. The Goldman Sachs Group increased their price objective on shares of HCA Healthcare from $470.00 to $520.00 and gave the stock a “buy” rating in a research report on Monday, October 27th. Jefferies Financial Group upped their price target on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. Royal Bank Of Canada upped their target price on HCA Healthcare from $449.00 to $482.00 and gave the company an “outperform” rating in a research report on Monday, October 27th. Finally, Oppenheimer boosted their price target on HCA Healthcare from $400.00 to $500.00 and gave the company an “outperform” rating in a research note on Monday, October 27th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and ten have given a Hold rating to the stock. According to MarketBeat, HCA Healthcare presently has an average rating of “Moderate Buy” and an average price target of $474.53.

Insider Activity

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the transaction, the executive vice president directly owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Michael R. Mcalevey sold 3,892 shares of HCA Healthcare stock in a transaction on Wednesday, November 5th. The shares were sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the transaction, the executive vice president owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. This trade represents a 52.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 1.30% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.